Sinco Pharmaceuticals Holdings Limited (HKG:6833)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1600
-0.0040 (-2.44%)
Aug 20, 2026, 9:44 AM HKT

HKG:6833 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
34.8542.0542.3569.46135.08
Depreciation & Amortization
25.524.4216.3211.366.68
Other Amortization
0.080.080-0.02
Loss (Gain) From Sale of Assets
-1.14-0.04--
Loss (Gain) From Sale of Investments
----0.28-0.16
Provision & Write-off of Bad Debts
7.1-3.924.256.211.02
Other Operating Activities
39.428.6445.97-5.9722.5
Change in Accounts Receivable
4.08-71.98-195.89-133.87364.07
Change in Inventory
92.78-244.31-19.88-26.88181.29
Change in Accounts Payable
21.3655.39444.18-21.2-277.39
Change in Unearned Revenue
-8.88-12.73-34.9747.68-0.06
Change in Other Net Operating Assets
-8.69-51.6551.41128.57-127.34
Operating Cash Flow
207.59-232.88353.775.08305.71
Operating Cash Flow Growth
--371.09%-75.44%122.66%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-10.03-35.16-29.55-52.69-23.52
Sale of Property, Plant & Equipment
0.01-0.910.3-
Cash Acquisitions
----68-
Sale (Purchase) of Intangibles
-17.78-17.92-15.11--
Other Investing Activities
-0.21-19.871.120.8
Investing Cash Flow
-27.81-52.87-63.63-119.27-22.73

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
298.92361.1180.02180210
Total Debt Issued
298.92361.1180.02180210
Long-Term Debt Repaid
-466.05-306.34-123.97-341.45-78.66
Total Debt Repaid
-466.05-306.34-123.97-341.45-78.66
Net Debt Issued (Repaid)
-167.1354.7656.05-161.45131.34
Issuance of Common Stock
---159.4675.37
Common Dividends Paid
-3.67-7.22-18.11--
Other Financing Activities
-65.28107.05-227.6637.03-303.83
Financing Cash Flow
-236.08154.59-189.7335.04-97.11

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-2.821.568.4312.24-3.59
Net Cash Flow
-59.12-129.6108.783.09182.29

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
197.55-268.04324.1522.39282.19
Free Cash Flow Growth
--1347.74%-92.07%106.09%
Free Cash Flow Margin
9.48%-9.50%12.76%0.99%13.94%
Free Cash Flow Per Share
0.10-0.130.160.010.16
Levered Free Cash Flow
116.17-175.42111.7857.81-85.98
Unlevered Free Cash Flow
125.77-167.57117.9166.44-72.58

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
33.9416.6414.4318.3322.47
Cash Income Tax Paid
19.0962.237.3739.6641.69
Change in Working Capital
100.65-325.27244.85-5.7140.57